
Forecasted sales for Yervoy worldwide by application area 2020-2026
By 2025, it is forecasted that 870 million U.S. dollars will be generated by cancer drug Yervoy for the treatment of non-small cell lung cancer, compared to 105 U.S. million dollars in 2020. This statistic illustrates the forecasted annual sales growth for Yervoy worldwide from 2020 to 2026. by area of application within cancer treatment.